Pfizer Breathes Easy: FDA Approves Exubera

Pfizer's Exubera is the first inhaled insulin to clear FDA; labeling recommends lung function testing.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet